Skip to content
User

Gardner Russo & Quinn ERFSF trades

Thomas Russo

Thomas Russo Eurofins Scientific SE stake

total: 273

Trades details

Total transactions:
3
New positions:
1
Added:
1
Reduced:
1
Held since:
2026 Q1
Held for:
3 quarters
Latest activity:
2026 Q3
According to 2026 Q3 report, Thomas Russo holds 3,948,382 Eurofins Scientific SE (ERFSF) shares with a market value of roughly $336.36M accounting for 4.00% of the overall portfolio. To date, the estimated cost basis is nearly $73.71 for "buy" trades and estimated average "sell" price is $85.19. Gardner Russo & Quinn first purchased ERFSF in 2026 Q1, initially acquiring about 3.10M shares. Since the initial investment in Eurofins Scientific SE (ERFSF), Gardner Russo & Quinn has made 2 more transactions.

How many ERFSF shares does Thomas Russo currently hold?

According to 2026 Q3 report, Thomas Russo holds 3,948,382 shares of Eurofins Scientific SE (ERFSF), valued at around $336.36M.

When did Thomas Russo buy Eurofins Scientific SE (ERFSF)?

Thomas Russo first invested in Eurofins Scientific SE (ERFSF) in 2026 Q1 at the reported quarter-end price of $72.20 per share.

What's the cost basis of Gardner Russo & Quinn's ERFSF stake?

The estimated cost basis for Eurofins Scientific SE (ERFSF) stake is around $73.71 per share. This represents their average reported price* across all buy transactions

Estimated cost basis*

Weighted AVG buy price:
$73.70
Weighted AVG sell price:
$85.19

Thomas Russo's historical trades in Eurofins Scientific SE

3 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2026 Q3
4.00%
3,948,382
$85.19
$336,357,727
-3.56% (-145,652)
-0.14%
2026 Q2
3.60%
4,094,034
$78.38
$320,909,414
+32.22% (+997,630)
+0.88%
2026 Q1
2.63%
3,096,404
$72.20
$223,550,621
new
+2.63%
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.